Cancer patient’s ‘scary ‘ abseil 160ft down London hospital for charity

  • 📰 Observer_Owl
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Claire Stork abseiled as Where’s Wally with her two friends to raise money for the charity supporting the hospital where she is undergoing…

A cancer patient who tackled her fear of heights by abseiling 160 feet down St Thomas’ Hospital in London dressed as Where’s Wally said the experience was “scary” but “well worth it”.

Ms Stork, 42, was watched by an “encouraging” audience who cheered for her and her friends, dubbed “the party animals”, as she abseiled down until her feet touched the ground. In January 2023 Ms Stork was diagnosed with a rare and highly aggressive form of thyroid gland cancer, anaplastic thyroid carcinoma, and is undergoing treatment.

“Since then I just want to pay back because they’ve done no more than help me – good days, bad days, however busy they are, they’re always there to help you.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 18. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cancer patient’s ‘scary ‘ abseil 160ft down London hospital for charityClaire Stork abseiled as Where’s Wally with her two friends to raise money for the charity supporting the hospital where she is undergoing…
Source: Glasgow_Times - 🏆 76. / 59 Read more »

Personalized cancer vaccine and adoptive T cell therapy benefits patients with advanced ovarian cancer: StudyA Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »